February 15, 2018

Blood Glucose Testing Frequency Correlates to A1c Reduction After 3 Months of Insulin Titration Utilizing Glucommander

In by Heather DelCarpini

Blood Glucose Testing Frequency Correlates to A1c Reduction After 3 Months of Insulin Titration Utilizing Glucommander Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2018 Authors Bruce Bode, John Clarke, Andrew Rhinehart, Robby Booth BACKGROUND Effective basal bolus insulin therapy requires dose titration to identify the right doses for each individual patient. Self-monitoring of blood glucose …

January 1, 2018

Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year

In by Heather DelCarpini

Use of Decision Support Software to Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year Publication Journal of Diabetes Science and Technology Date January 2018 Authors Bruce Bode,1 John G. Clarke,1 Joseph Johnson1 ABSTRACT Purpose: The purpose was to improve the quality of care of at-risk patients through the addition of connected BG meters and CDSS to improve workflow …

November 3, 2017

Utilization of Electronic Glucose Management Systems for Hospital Discharge Insulin Dosing

In by Heather DelCarpini

Utilization of Electronic Glucose Management Systems for Hospital Discharge Insulin Dosing Presentation Annual Diabetes Technology Meeting Date November 2017 Authors Jagdeesh Ullal, Raymie McFarland, H. Courtenay Harrison, Amy Bedingfield, Jessica Sheehan, Susan DeAbate, Christine Dignan, Rebecca Cwik, Genevieve Thompson, Paul Chidester INTRODUCTION This prospective quality improvement project evaluated the effectiveness an electronic glycemic management system (eGMS®) utilizing Glucommander™ and admission …

September 12, 2017

Use of Decision Support Software To Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year

In by Heather DelCarpini

Use of Decision Support Software To Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year Presentation European Association for the Study of Diabetes Annual Meeting Date September 2017 Authors Andrew Rhinehart, John Clarke, Robby Booth INTRODUCTION Multiple issues continue to plague diabetes management: High insulin attrition rates1 Ineffective doses of insulin and insufficient dose adjustments2 Insufficient adult endocrinologists …

February 15, 2017

Time To Target Using eGMS To Manage Inpatient Subcutaneous Insulin Basal Bolus Regimen

In by Heather DelCarpini

Time To Target Using eGMS To Manage Inpatient Subcutaneous Insulin Basal Bolus Regimen Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2017 Authors Bruce Bode,1 Courtenay Harrison2 OBJECTIVE The importance of inpatient glycemic control on outcomes not only applies to patients managed with IV insulin in critical care areas but also patients on general surgical and …

Glucommander Outpatient, a Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months

In by Heather DelCarpini

Glucommander Outpatient, A Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months Presentation International Conference on Advanced Technologies & Treatments for Diabetes Date February 2017 Authors Bruce Bode,1 John Clarke1 BACKGROUND Treatment of diabetes with multiple daily injections (MDI), using a regimen of long-acting basal and rapid-acting bolus …

November 10, 2016

Relationship Between Glycemic Control Using eGMS and Readmission Rates in Cardiovascular Patients Hospitalized with AMI, CHF or Undergoing CABG During the Implementation of a System Wide Glycemic Initiative

In by Heather DelCarpini

Relationship Between Glycemic Control Using eGMS and Readmission Rates in Cardiovascular Patients Hospitalized with AMI, CHF or Undergoing CABG During the Implementation of a System Wide Glycemic Initiative Presentation Annual Diabetes Technology Meeting Date November 2016 Authors April Mumpower,1 Suqin Hou,2 Tamera Parsons,1 Raymie McFarland2 OBJECTIVE The CMS Hospital Readmission Reduction (HRR) program was initiated in 2012 to encourage hospitals …

Does Glycemic Control Using eGMS Reduce Readmission Rates for Hospitalized Patients Undergoing CABG?

In by Heather DelCarpini

Does Glycemic Control Using eGMS Reduce Readmission Rates for Hospitalized Patients Undergoing CABG? Presentation Annual Diabetes Technology Meeting Date November 2016 Authors April Mumpower,1 Tamera Parsons1 OBJECTIVE The CMS Hospital Readmission Reduction (HRR) program added Coronary Artery Bypass Grafting (CABG) to their list of diagnoses that will be measured beginning in October 2016. Hospitals will be penalized for readmission rates …

August 23, 2016

Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting

In by Heather DelCarpini

Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting Publication Journal of Diabetes Science and Technology Date August 2016 Authors Joseph Aloi,1 Bruce Bode,2 Jagdeesh Ullal,3 Paul Chidester,4 Raymie McFarland,5 Amy Bedingfield,5 Melanie Mabrey,5 Robby Booth,5 April Mumpower,6 Amisha Wallia7 ABSTRACT Background: American Diabetes Association (ADA) guidelines recommend a basal bolus …

June 12, 2016

A Comparison of Glycemic Outcomes for Two Computerized Insulin Infusion Algorithms in CV Surgery Patients

In by Heather DelCarpini

A Comparison of Glycemic Outcomes for Two Computerized Insulin Infusion Algorithms in CV Surgery Patients Presentation American Diabetes Association Scientific Sessions Date June 2016 Authors Valerie Garrett,1 Linda Fornoff,1 Jodie Becker,1 Raymie McFarland,2 Robby Booth,2 Amy Henderson2 BACKGROUND Hyperglycemia in patients undergoing cardiovascular (CV) surgery is an independent risk factor for increased morbidity and mortality. Studies have shown that optimal …

Glucommander Outpatient, a Cloud-Based Insulin Management Solution Adjusted Insulin Doses and Achieved 2.7% Drop in A1c Percentage Points

In by Heather DelCarpini

Glucommander Outpatient, a Cloud-Based Insulin Management Solution Adjusted Insulin Doses and Achieved 2.7% Drop in A1c Percentage Points Presentation American Diabetes Association Scientific Sessions Date June 2016 Authors John Clarke, Bruce Bode, Robby Booth, Harry Hebblewhite BACKGROUND Treatment of diabetes with multiple daily injections, using a regimen of basal and rapid-acting insulins is widely accepted as the standard of care. …

October 12, 2012

A Computer Program, Directed by Clinicians for Outpatients, Which Re-adjusts Subcutaneous Multiple Daily Injections (MDI) of Insulin, Achieves an Improvement of 2.6 A1c% Points

In by Heather DelCarpini

A Computer Program, Directed by Clinicians for Outpatients, Which Re-adjusts Subcutaneous Multiple Daily Injections (MDI) of Insulin, Achieves an Improvement of 2.6 A1c% Points Presentation International Hospital Diabetes Meeting Date October 2012 Authors PC Davidson,1 BW Bode,1 HR Hebblewhite,2 R Booth2 PURPOSE This study examines the performance of a computerized algorithm for adjusting subcutaneous basal-bolus MDI insulin regimens for outpatients. …